All Stories

  1. Smoking Cessation as a Possible Risk Factor for the Development of Aspirin-Exacerbated Respiratory Disease in Smokers

    Article • The Journal of Allergy and Clinical Immunology In Practice, June 2017, Elsevier

    Hiroaki Hayashi

  2. Omalizumab reduces cysteinyl leukotriene and 9α,11β-prostaglandin F 2 overproduction in aspirin-exacerbated respiratory disease

    Article • Journal of Allergy and Clinical Immunology, May 2016, Elsevier

    Hiroaki Hayashi

  3. Platelet activation markers overexpressed specifically in patients with aspirin-exacerbated respiratory disease

    Article • Journal of Allergy and Clinical Immunology, February 2016, Elsevier

    Hiroaki Hayashi

  4. Age-Specific Characteristics of Inpatients with Severe Asthma Exacerbation

    Article • Allergology International, January 2013, Japanese Society of Allergology

    Hiroaki Hayashi